HKD 5.76
(-2.54%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.86 Billion HKD | 12.43% |
2022 | 3.43 Billion HKD | 6.36% |
2021 | 3.22 Billion HKD | 27.82% |
2020 | 2.52 Billion HKD | -11.89% |
2019 | 2.86 Billion HKD | 37.22% |
2018 | 2.08 Billion HKD | 19.4% |
2017 | 1.74 Billion HKD | 40.05% |
2016 | 1.24 Billion HKD | 27.26% |
2015 | 981.75 Million HKD | 10.05% |
2014 | 892.05 Million HKD | 29.16% |
2013 | 690.67 Million HKD | 36.57% |
2012 | 505.74 Million HKD | 29.77% |
2011 | 389.73 Million HKD | 105.71% |
2010 | 189.46 Million HKD | -3.77% |
2009 | 196.88 Million HKD | 81.23% |
2008 | 108.63 Million HKD | 54.81% |
2007 | 70.17 Million HKD | 73.91% |
2006 | 40.35 Million HKD | -70.1% |
2005 | 134.97 Million HKD | -23.78% |
2004 | 177.07 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 2.21 Billion HKD | 0.0% |
2023 FY | 3.86 Billion HKD | 12.43% |
2023 Q2 | 2.33 Billion HKD | 0.0% |
2023 Q4 | 1.52 Billion HKD | 0.0% |
2022 FY | 3.43 Billion HKD | 6.36% |
2022 Q2 | 1.92 Billion HKD | 0.0% |
2022 Q4 | 1.44 Billion HKD | 0.0% |
2021 Q4 | 1.43 Billion HKD | 0.0% |
2021 FY | 3.22 Billion HKD | 27.82% |
2021 Q2 | 1.84 Billion HKD | 0.0% |
2020 Q4 | 1.28 Billion HKD | 0.0% |
2020 Q2 | 1.24 Billion HKD | 0.0% |
2020 FY | 2.52 Billion HKD | -11.89% |
2019 Q4 | 1.27 Billion HKD | 0.0% |
2019 FY | 2.86 Billion HKD | 37.22% |
2019 Q2 | 1.58 Billion HKD | 0.0% |
2018 FY | 2.08 Billion HKD | 19.4% |
2018 Q2 | 1.35 Billion HKD | 0.0% |
2018 Q4 | 735.81 Million HKD | 0.0% |
2017 FY | 1.74 Billion HKD | 40.05% |
2017 Q2 | 802.11 Million HKD | 0.0% |
2017 Q4 | 947.64 Million HKD | 0.0% |
2016 Q4 | 704.62 Million HKD | 0.0% |
2016 Q2 | 544.73 Million HKD | 0.0% |
2016 FY | 1.24 Billion HKD | 27.26% |
2015 Q4 | 532.63 Million HKD | 0.0% |
2015 Q2 | 449.11 Million HKD | 0.0% |
2015 FY | 981.75 Million HKD | 10.05% |
2014 Q4 | 441.49 Million HKD | 0.0% |
2014 Q2 | 450.56 Million HKD | 0.0% |
2014 FY | 892.05 Million HKD | 29.16% |
2013 Q4 | 344.15 Million HKD | 0.0% |
2013 FY | 690.67 Million HKD | 36.57% |
2013 Q2 | 346.52 Million HKD | 0.0% |
2012 Q2 | 127.12 Million HKD | 0.0% |
2012 FY | 505.74 Million HKD | 29.77% |
2012 Q4 | 177.07 Million HKD | 39.3% |
2012 Q3 | 127.12 Million HKD | 0.0% |
2012 Q1 | 127.12 Million HKD | 0.0% |
2011 Q2 | 97.43 Million HKD | 0.0% |
2011 Q3 | 97.43 Million HKD | 0.0% |
2011 Q4 | 127.12 Million HKD | 30.47% |
2011 FY | 389.73 Million HKD | 105.71% |
2011 Q1 | 97.43 Million HKD | 0.0% |
2010 Q1 | 47.36 Million HKD | 0.0% |
2010 Q3 | 47.36 Million HKD | 0.0% |
2010 Q4 | 97.43 Million HKD | 105.71% |
2010 FY | 189.46 Million HKD | -3.77% |
2010 Q2 | 47.36 Million HKD | 0.0% |
2009 Q1 | 49.22 Million HKD | 0.0% |
2009 Q3 | 49.22 Million HKD | 0.0% |
2009 Q4 | 47.36 Million HKD | -3.77% |
2009 FY | 196.88 Million HKD | 81.23% |
2009 Q2 | 49.22 Million HKD | 0.0% |
2008 Q2 | 27.15 Million HKD | 0.0% |
2008 Q4 | 49.22 Million HKD | 81.23% |
2008 Q1 | 27.15 Million HKD | 0.0% |
2008 FY | 108.63 Million HKD | 54.81% |
2008 Q3 | 27.15 Million HKD | 0.0% |
2007 Q1 | 17.54 Million HKD | 0.0% |
2007 Q4 | 27.15 Million HKD | 54.81% |
2007 Q3 | 17.54 Million HKD | 0.0% |
2007 Q2 | 17.54 Million HKD | 0.0% |
2007 FY | 70.17 Million HKD | 73.91% |
2006 Q4 | 17.54 Million HKD | 73.91% |
2006 FY | 40.35 Million HKD | -70.1% |
2006 Q2 | 10.08 Million HKD | 0.0% |
2006 Q3 | 10.08 Million HKD | 0.0% |
2006 Q1 | 10.08 Million HKD | 0.0% |
2005 Q2 | 33.74 Million HKD | 0.0% |
2005 Q4 | 10.08 Million HKD | -70.1% |
2005 FY | 134.97 Million HKD | -23.78% |
2005 Q1 | 33.74 Million HKD | 0.0% |
2005 Q3 | 33.74 Million HKD | 0.0% |
2004 Q2 | 44.26 Million HKD | 0.0% |
2004 Q3 | 44.26 Million HKD | 0.0% |
2004 Q1 | 44.26 Million HKD | 0.0% |
2004 Q4 | 33.74 Million HKD | -23.78% |
2004 FY | 177.07 Million HKD | 0.0% |
2003 Q4 | 44.26 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Pak Fah Yeow International Limited | 24.42 Million HKD | -15706.866% |
Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -10766.859% |
Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -990.791% |
Qianhai Health Holdings Limited | 17.1 Million HKD | -22474.371% |
Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -553.252% |
Essex Bio-Technology Limited | 1.22 Billion HKD | -214.14% |
Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -666.823% |
PuraPharm Corporation Limited | 216.62 Million HKD | -1682.157% |
SSY Group Limited | 1.98 Billion HKD | -94.911% |
JBM (Healthcare) Limited | 163.87 Million HKD | -2255.848% |
Jacobson Pharma Corporation Limited | 287.34 Million HKD | -1243.547% |
China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 86.848% |